Dyslipidemia

An analysis of data from patients presenting to a medical center in New York City details associations between statin use and mortality among diabetics hospitalized with COVID-19.

An analysis of the Dallas Heart Study from UTSW details how use of CAC scoring can help determine what patients would stand to benefit from aspirin use for primary prevention.

In a recent column, Paul Thompson, MD, reviews an email exchange he had with a colleague seeking perspective for a patient with statin-induced autoimmune myopathy.

Dr. Albert discusses how preventative care and access to health care are important in closing health discrepancies.

Dr. Albert discusses some ways to close the racial outcome gaps in cardiology.

In a submitted column, Dr. Gregory Weiss reflects on the importance of adherence to cholesterol-lowering medications and including statins in treatment regimens.

Results of REDUCE-IT PCI detail a 34% reduction in 5-point MACE and a 39% reduction in total events among patients receiving icosapent ethyl (Vascepa) in the original trial with a history of PCI.

The LIVMOR Halo AF Detection System has received 510(k) clearance from the US FDA and becomes the first prescriptible wearable for continuous heart monitoring in patients with atrial fibrillation.

Only 29.5% of sampled CBD users claimed any wellness benefit.